Remove 2018 Remove Compliance Remove DEA Remove Safety
article thumbnail

DEA-Licensed Biopharmaceutical Research Company to Partner with CURE Pharmaceutical to Produce Federally-Compliant Cannabis-Based Medical Products

Cannabis Law Report

MONTEREY, CA – Biopharmaceutical Research Company (BRC), an active Drug Enforcement Administration (DEA) license holder, and CURE Pharmaceutical Holding Corp. CURE currently produces multiple commercial CBD oral film products in compliance with the 2018 U.S.Farm Bill and European regulations.

DEA 59
article thumbnail

CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health

Cannabis Law Report

(OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company , (BRC), an active Drug Enforcement Administration (DEA) license holder, to produce federally-compliant cannabis-based medical products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Hemp Testing Guidelines Make Meeting 0.3% THC Limit Difficult

Medicinal Genomics

The 2018 Farm Bill also closed a loophole that allowed high THCA plants to meet the 0.3% The 2018 bill specified that labs must use a “post-decarboxylation or other similarly reliable” method for detecting THC. No existing cannabis labs are registered with the DEA because they handle a schedule 1 substance, which violates federal law.

THC 81
article thumbnail

What CBD Shutdowns Mean and How to Fix the Problem

Cannabis Law Report

In the early months of 2019, and after the recent passage of the 2018 Farm Bill, an increasing number of state and municipal agencies continue to pay close attention to hemp-derived CBD products, in some cases leaving products under siege by regulators. If you wish to re-publish this story please do so with following accreditation.

CBD 71
article thumbnail

Is Delta-8 THC a Controlled Substance? Yes. No. Maybe. – Cannabis Business Executive

SpeedWeed

Although all hemp-derived cannabinoids, including hemp-derived Delta-8 THC, seem to fall squarely within the definition of hemp enacted under the Agriculture Improvement Act of 2018 (the “ 2018 Farm Bill”) , uncertainties remain regarding the federal legality of cannabinoids like Delta-8 THC that are derivatives of other hemp-derived cannabinoids.

THC 52
article thumbnail

How long will delta-8 remain legal?

SpeedWeed

Due to ambiguities in the 2018 farm bill, which legalized hemp and hemp products, delta-8 is currently not prohibited by federal law. Many states are now scrambling to close legal loopholes in their drug laws to bring delta-8 into regulatory compliance. Andrea Golan expects a federal response to delta-8 will first come from the DEA. “We

article thumbnail

Religious Use of Psychedelic Drugs Under Federal Law: A History

Canna Law Blog

According to the CSA (and subsequent regulations ), Schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. Presumably, these requirements provided justification for the DEA to burden these religious exemptions.

History 98